Zurex Pharma, a Middleton, WI-based company developing antimicrobial products for preventing infections acquired in hospitals, clinics, and home care settings, says it has raised more than $9 million in new funding. Zurex says it plans to use some of the proceeds from the investment to support the development of its lead product candidate, a pre-surgical skin preparation called ZurexPrep.
“We remain focused on working toward our first product approval [and] ongoing product development activities,” Zurex CEO Carmine Durham says in an e-mail.
According to a press release, Zurex’s existing shareholders led the round. Square 1 Bank, a division of Pacific Western Bank, was the only new investor Zurex named in the release. The company’s previous backers include Baird Venture Partners, Peak Ridge Capital, the State of Wisconsin Investment Board, and Wisconsin Investment Partners.
Read more at Xconomy.